Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (Duration of Dual Antiplatelet Therapy AfterImplantation of Endeavor Stent) registry. [electronic resource]
Producer: 20101130Description: 2314-21 p. digitalISSN:- 1347-4820
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Aspirin -- administration & dosage
- Cardiovascular Agents -- administration & dosage
- Chi-Square Distribution
- Clopidogrel
- Coronary Angiography
- Coronary Stenosis -- diagnostic imaging
- Disease-Free Survival
- Drug Administration Schedule
- Drug Therapy, Combination
- Drug-Eluting Stents
- Feasibility Studies
- Female
- Humans
- Kaplan-Meier Estimate
- Logistic Models
- Male
- Middle Aged
- Myocardial Infarction -- etiology
- Platelet Aggregation Inhibitors -- administration & dosage
- Propensity Score
- Proportional Hazards Models
- Prospective Studies
- Prosthesis Design
- Registries
- Republic of Korea
- Risk Assessment
- Risk Factors
- Sirolimus -- administration & dosage
- Thrombosis -- etiology
- Ticlopidine -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.